Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00608751 · ClinicalTrials.gov registry record · Early Phase 1
A Feasibility Study of Adaptive Intensity-Modulated Radiation Therapy
A Early Phase 1 study, sponsored by Washington University School of Medicine.
- Terminated
- Registry status
- Early Phase 1
- Development phase
- 5
- Enrollment target
NCT00608751 is a Early Phase 1 study that was terminated before completion, run by Washington University School of Medicine. The registered enrollment target is 5 participants.
The verdict
NCT00608751, a Early Phase 1 study, was terminated before completion, sponsored by Washington University School of Medicine.
- TERMINATED
- Registry status
- Early Phase 1
- Development phase
- 5 participants
- Enrollment target
Study Summary
Patients with head and neck cancer and are schedule to receive standard radiation therapy known as IMRT to treat cancer
Interventions
- RADIATION IMRT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2007-01 |
| Est. Completion | 2008-01 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00608751
The ClinicalTrials.gov registry entry for NCT00608751 describes a study currently listed as terminated, categorized as Early Phase 1. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which IMRT is the first listed.
NCT00608751 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00608751 about?
NCT00608751 is a clinical study titled "A Feasibility Study of Adaptive Intensity-Modulated Radiation Therapy". Patients with head and neck cancer and are schedule to receive standard radiation therapy known as IMRT to treat cancer
What is the current status of trial NCT00608751?
This trial is currently terminated. It is a Early Phase 1 study. The enrollment target is 5 participants. The study started on 2007-01. Estimated completion is 2008-01.
What interventions are being tested in trial NCT00608751?
The interventions under investigation include: IMRT (RADIATION).
Who is sponsoring clinical trial NCT00608751?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.